CBD and brain cancer: What scientific studies say

Cannabidiol is the subject of extensive scientific work aimed at evaluating its potential in various fields of health. Among the areas of research explored by the medical community, the impact of CBD on brain tumor cells is of particular interest, especially regarding glioblastoma multiforme (GBM), the most common and severe form of primary brain tumor in adults.

Cellular mechanisms targeted by research

A study published by scientists from the School of Human Sciences at London Metropolitan University, building on previous work by Professor Pierre-Yves Desprez (California Pacific Medical Center in San Francisco), examined the action of CBD against the proliferation of GBM cells.

The researchers analyzed two key factors of tumor resistance:

• Extracellular vesicles (EVs): These biological structures facilitate the transfer of proteins and genetic material, playing a central role in the communication and progression of tumor cells.
• Prohibitin: A protein whose overexpression contributes to the resistance of cancer cells to chemotherapy agents.

CBD and chemotherapy: The synergistic action hypothesis

During their experiments, the researchers evaluated the behavior of glioblastoma cells exposed to CBD, in the presence and absence of temozolomide, a standard chemotherapeutic agent.

The laboratory results indicate that CBD acts as a modulator of extracellular vesicles:

1. Increased tumor sensitivity: By modifying the profile of extracellular vesicles, CBD helps make cancer cells more receptive to the action of chemotherapy.
2. Reduction of prohibitin: CBD treatment showed a decrease in prohibitin levels, thereby limiting one of the tumor's defense mechanisms.

These findings lead the study's authors to suggest that cannabidiol could, subject to further clinical research, constitute an interesting adjuvant to enhance the efficacy of conventional glioblastoma treatments. If you would like to learn more about the extraction of hemp molecules, you can discover our organic full-spectrum CBD oils.

Essential warning

The data presented are derived from fundamental research conducted in a laboratory setting (in vitro). CBD is not a medical treatment for brain cancer and cannot in any way replace oncology protocols prescribed by medical teams.

Frequently Asked Questions

1. What do studies say about CBD and glioblastoma?

   In vitro research (London Metropolitan University) indicates that CBD modulates extracellular vesicles and reduces prohibitin, which could increase the sensitivity of glioblastoma cells to chemotherapy (temozolomide).

2. Can CBD replace chemotherapy for brain cancer?

   Absolutely not. CBD is not an anticancer drug. The studies focus solely on its potential role as an adjuvant in laboratory research. Any oncological treatment must be followed under strict medical supervision.

3. What is the role of extracellular vesicles (EVs) in the work on CBD?

   EVs allow for communication between cancer cells. The study demonstrates that CBD modifies the profile of these vesicles, making tumor cells less resistant to chemical agents.

4. Can CBD be consumed during chemotherapy treatment?

   Any use of CBD in parallel with chemotherapy must be subject to prior approval by the oncologist to avoid any risk of drug interactions with ongoing treatments.